Prozac Patent Challenge Trial To Last Two Weeks After Rulings Reduce Scope
The patent challenge trial for Eli Lilly's Prozac is expected to run for two weeks after pre-trial rulings limited the issues Barr could bring against Lilly.
The patent challenge trial for Eli Lilly's Prozac is expected to run for two weeks after pre-trial rulings limited the issues Barr could bring against Lilly.